Therapeutic siRNA: state of the art
Hu, B; Zhong, LP; Weng, YH; Peng, L; Huang, YY; Zhao, YX; Liang, XJ
Huang, YY (corresponding author), Beijing Inst Technol, Adv Res Inst Multidisciplinary Sci, Inst Engn Med, Sch Life Sci,Key Lab Mol Med & Biotherapy, Beijing 100081, Peoples R China.; Zhao, YX (corresponding author), Guangxi Med Univ, Natl Ctr Int Biotargeting Theranost, Collaborat Innovat Ctr Targeting Tumor Theranost, Guangxi Key Lab Biotargeting Theranost, Nanning 530021, Guangxi, Peoples R China.; Liang, XJ (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Nanosci, Natl Ctr Nanosci & Technol China, Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020; 5 (1):